These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7667833

  • 1. Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA.
    Heeremans JL, Prevost R, Bekkers ME, Los P, Emeis JJ, Kluft C, Crommelin DJ.
    Thromb Haemost; 1995 Mar; 73(3):488-94. PubMed ID: 7667833
    [Abstract] [Full Text] [Related]

  • 2. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G, Pascucci C, Nenci GG, Mele A, Bürgi R, Heim J.
    Thromb Haemost; 1993 Aug 02; 70(2):294-300. PubMed ID: 8236138
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits.
    Agnelli G, Pascucci C, Colucci M, Nenci GG, Mele A, Bürgi R, Heim J.
    Thromb Haemost; 1992 Sep 07; 68(3):331-5. PubMed ID: 1440500
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D, Stassen JM, Yasuda T, Refino C, Paoni N, Keyt B, Roskams T, Guerrero JL, Lijnen HR, Gold HK.
    Thromb Haemost; 1994 Jul 07; 72(1):98-104. PubMed ID: 7974384
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.
    Thomas GR, Thibodeaux H, Bennett WF, Refino CJ, Badillo JM, Errett CJ, Zivin JA.
    J Pharmacol Exp Ther; 1993 Jan 07; 264(1):67-73. PubMed ID: 8423552
    [Abstract] [Full Text] [Related]

  • 12. Function of tissue-type plasminogen activator releaser on vascular endothelial cells and thrombolysis in vivo.
    Ueshima S, Matsuno H, Hayashi M, Horibuchi K, Okada K, Fukao H, Uematsu T, Matsuo O.
    Thromb Haemost; 2002 Jun 07; 87(6):1069-74. PubMed ID: 12083488
    [Abstract] [Full Text] [Related]

  • 13. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization.
    Rahman F.
    Fukuoka Igaku Zasshi; 1990 Sep 07; 81(9):303-12. PubMed ID: 2125971
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Influence of the fast-acting inhibitor of plasminogen activator on in vivo thrombolysis induced by tissue-type plasminogen activator in rabbits. Interference of tissue-derived components.
    Colucci M, Paramo JA, Stassen JM, Collen D.
    J Clin Invest; 1986 Jul 07; 78(1):138-44. PubMed ID: 3088040
    [Abstract] [Full Text] [Related]

  • 17. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 07; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 18. Effects of liver blood flow on the pharmacokinetics of tissue-type plasminogen activator (alteplase) during thrombolysis in patients with acute myocardial infarction.
    van Griensven JM, Koster RW, Burggraaf J, Huisman LG, Kluft C, Kroon R, Schoemaker RC, Cohen AF.
    Clin Pharmacol Ther; 1998 Jan 07; 63(1):39-47. PubMed ID: 9465840
    [Abstract] [Full Text] [Related]

  • 19. Biological properties of human tissue-type plasminogen activator obtained by expression of recombinant DNA in mammalian cells.
    Collen D, Stassen JM, Marafino BJ, Builder S, De Cock F, Ogez J, Tajiri D, Pennica D, Bennett WF, Salwa J.
    J Pharmacol Exp Ther; 1984 Oct 07; 231(1):146-52. PubMed ID: 6541693
    [Abstract] [Full Text] [Related]

  • 20. [The effect of T-PA on thrombosis, an experimental study].
    Gu YD.
    Zhonghua Wai Ke Za Zhi; 1991 Oct 07; 29(10):605-7, 652-3. PubMed ID: 1815902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.